Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

September 27, 2005

Primary Completion Date

December 30, 2013

Study Completion Date

August 11, 2026

Conditions

Breast Cancer

Interventions

DRUG

cyclophosphamide

Given IV

DRUG

docetaxel

Given IV

DRUG

doxorubicin hydrochloride

Given IV

BIOLOGICAL

Trastuzumab

Given IV

DRUG

Carboplatin

Given IV

DRUG

Paclitaxel

Given IV

Trial Locations (1)

City of Hope Medical Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER